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Background: Chronic pain is a common reason for consultation in general practice. Current research distinguishes
between chronic localized pain (CLP) and chronic widespread pain (CWP). The aim of this study was to identify
differences between CWP and chronic low back pain (CLBP), a common type of CLP, in primary care settings.
Methods: Fifty-eight German general practitioners (GPs) consecutively recruited all eligible patients who consulted
for chronic low back pain during a 5-month period. All patients received a questionnaire on sociodemographic
data, pain characteristics, comorbidities, psychosomatic symptoms, and previous therapies.
Results: GPs recruited 647 eligible patients where of a quarter (n = 163, 25.2%) met the CWP criteria according to
the American College of Rheumatology. CWP patients had significantly more comorbidities and psychosomatic
symptoms, showed longer pain duration, and suffered predominantly from permanent pain instead of
distinguishable pain attacks. CWP patients were more often females, are less working and reported a current
pension application or a state-approved grade of disability more frequently. We found no other differences in
demographic parameters such as age, nationality, marital status, number of persons in household, education, health
insurance status, or in health care utilization data.
Conclusions: This project is the largest study performed to date which analyzes differences between CLBP and
CWP in primary care settings. Our results showed that CWP is a frequent and particularly severe pain syndrome.
Trial registration: German Clinical Trial Register, DRKS00003123.
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Chronic pain is a common reason for consultation in gen-
eral practice. Current research distinguishes between
chronic localized pain (CLP) and chronic widespread pain
(CWP). CLP is defined as chronic pain restricted to one or
few body regions (e.g. head, back, or knee). In contrast,
CWP means chronic pain in several body regions. The
American College of Rheumatology (ACR) defines CWP
as pain in the left and right side of the body, as well as* Correspondence: annika.viniol@staff.uni-marburg.de
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[1]. It is still unclear whether CWP is a complication of
CLP or an independent pain syndrome [2].
Population based studies reported a CWP point-
prevalence of 4.7%-15% depending on the country [3-8].
Nordeman et al. found a CWP prevalence of 28% in a
sample of female chronic low back pain (CLBP) patients
consulting primary care in Sweden [9]. The high CWP
prevalence and the associated high social and economic
burden for patients and health care systems [10] illus-
trate the need for further knowledge about CWP.
Several studies have investigated differences in physical
and psychological factors between CWP patients andtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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male, older, less educated [11], have a decreased health-
related quality of life [7,11], are less physically active
[12], and a receive disability pension more often [13]
than patients without pain. They show a high prevalence
of physical and psychological comorbidities [4,6,14-17]
and an increased mortality risk [18].
In addition to differences in the pain distribution, it is
also important to know if CWP patients are more nega-
tively affected in other wellbeing areas when compared
to CLP patients.
To date, few studies have examined differences between
CWP and CLP. Two studies present population based data
on neck-shoulder pain [19] and myofacial face pain [20].
They found a higher rate of pain intensity, pain duration, de-
pression, and somatization symptoms among CWP patients.
Among all CLP syndromes, CLBP is the most common
[21]. Back pain is the second most frequent consultation
reason in German primary care practices [22].
Only one study investigated differences of CLBP and
CWP in primary care patients: Nordeman et al. [9] found
an increased rate of activity limitation, impaired physical
performance, work disability, severe pain, tender points,
fatigue, depression, and severe clinical stress symptoms in
CWP patients compared to CLBP patients. The authors
also reported a lower health-related quality of life and a re-
duced private social support in CWP patients [9]. How-
ever, Nordeman et al. studied only women.
The aim of this study is to identify differences between
CWP and chronic low back pain (CLBP), a common type
of CLP, in primary care settings. This would enable us to
suggest priorities for health care interventions in CWP.
Methods
Study design
The present study refers to the cross sectional baseline
analysis of a 12-month cohort study which evaluates risk
factors and protective factors of pain generalization in
primary care CLBP patients. A detailed study protocol
has been published elsewhere [23].
This project is part of the research consortium LOGIN
“Localized and Generalized Musculoskeletal Pain: Psycho-
biological Mechanisms and Implications for Treatment”
funded by the German Federal Ministry of Education and
Research. The study was approved by the local ethics
commission of Philipps University in Marburg, Germany
(Ethik: 11.06.2010, AZ 88/10) and is in accordance with
the Declaration of Helsinki.
Study population
We invited all general practitioners (GPs) in the north-
ern part of Germany’s state of Hessen to participate in
our study. We asked participating GPs to consecutively
recruit all eligible patients consulting for CLBP as aprimary or secondary consulting reason (inclusion cri-
teria), during a 5-month period. The symptom “chronic
low back pain” was defined as pain in the back area
under the costal arch, but over the bottom fold (with or
without pain radiation), during most days in the last
three months. Patients under 18 years, pregnant women,
and patients with insufficient understanding of the German
language or severe cognitive impairments (e.g., dementia)
were excluded from the study.
Data collection
Doctors asked patients for study participation directly
after consultation. All participating patients received a
pen and paper questionnaire. Patients who refrained
from participation were asked to give reasons for their
decline. During the recruitment period, trained clinical
monitors conducted two random quality control checks
of the GPs’ performance.
Measurements
To explore distinctive features with regards to pain char-
acteristics and sociodemographic data between CLBP
and CWP patients, we evaluated the following physical
and psychological parameters (for detailed information
please see Viniol et al. [23]).
Pain characteristics and sociodemographic data
For definition of CLBP and CWP, we assessed pain
localization with the body pain drawing model from Pfau
et al. [24]. The CWP definition was derived from the
ACR criteria from Wolfe et al. [1]. Pain anamnesis was
assessed with the German Pain Questionnaire, the offi-
cial pain questionnaire of the German Association for
the Study of Pain [25]. We chose the modules referring
to duration, characteristics, course of pain, sociodemo-
graphic data, health care utilization, and medication.
In addition, we used the 3-item social support subscale
of the West Haven-Yale Multidimensional Pain Inventory
(MPI) to explore the partner’s reaction in response to pa-
tient’s pain (internal consistency of the subscales: α = 0.63-
0.90) [26,27]. We rated the severity of chronic pain with
the German translation of von Korff ’s Graded Chronic
Pain questionnaire [28]. Severity is computed from “pain
intensity” and “pain-related disability” (internal consistency
of the subscales: α = 0.68-0.88). The lower range of the
scale is determined by pain intensity; the higher range
of the scale refers to pain intensity and pain-related
disability [29].
Comorbidities
Using the Self-Administered Comorbidity Questionnaire,
we asked the patients about 14 common medical condi-
tions (high blood pressure, heart disease, asthma,
chronic obstructive pulmonary disease, ulcer/stomach
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osteoarthritis/degenerative arthritis, rheumatoid arthritis,
osteoporosis, cancer disease, depression, other psychiatric
diseases) [8,30]. Patients were asked to specify if they suf-
fer from any of these traits, whether they receive treat-
ment for it, and whether it causes functional limitations.
Psychosomatic symptoms
The Symptom Checklist-90-R (SCL-90-R) assess typical
physical symptoms which accompany functional dys-
functions, but could also arise in somatic disorders.
The SCL-90-R is a commonly used psychological sta-
tus symptom inventory for psychopathology (internal
consistency: α = 0.81) [31].
General practitioners case report
Potential red flags, which are frequently used risk factors
for identifying serious disorders causing low back pain,
were documented by the GPs for each patient [32].
Statistical analysis
We calculated summary statistics (mean, median, stand-
ard deviation, percentiles, frequencies, and percentages)
for each of the two study groups, i.e., CWP and CLBP.
Testing for differences in outcome variables between
CWP and CLBP patients was done using chi-square tests
(for categorical data with expected cell frequencies of
n ≥ 5), Fisher’s exact tests (for categorical data with ex-
pected cell frequencies of n < 5), t-tests accounting for
unequal variances (Welsh tests), and Mann–Whitney U
tests (for ordinal data).
Results
Enrollment of general practitioners and patients
Fifty-eight of the 284-invited GPs (20.4%) participated in
the study. The majority of them were male (58.6%), aver-
aged 53 years old, and worked in practices with differing
sizes from both urban and rural locations and having
varying organizational structures (solo/group practices).
During the recruitment period, 746 eligible patients
were asked to participate. Seventy-six patients declined
participation at once, and fifteen patients withdrew con-
sent when seeing the questionnaire. Therefore, 655 par-
ticipants completed the questionnaire. We excluded
eight additional subjects from analyses because they did
not report lower back pain on the pain drawing. A total
of, 647 patients were analysed.
Total group characteristics
A quarter of all participating CLBP patients (163, 25.2%)
met CWP criteria in the pain drawing. The majority
(52.1%) of all CLBP patients reported having back pain for
more than ten years. On average, the participating patients
were 56.5 years old. The majority was female (61.6%),married (65.1%), and lived in a two-person household
(48.6%). Half of the participants are working (50.5%). Of
the non-working participants, 75.2% were retired.
Differences between CLBP and CWP patients
Sociodemographic data
A higher fraction of females was observed among CWP
patients compared to CLBP patients (CWP 71.8% vs.
CLBP 57.6%). CWP patients were less working (CWP
52.8% vs. CLBP 43.6%). Reasons for not working were
comparable between groups. CWP patients more fre-
quently reported a current pension application (CWP
14.1% vs. CLBP 5.2%) and having a degree of disability
(CWP 54.2% vs. CLBP 38.5%). Other sociodemographic
parameters such as age, marital status, education and rea-
sons for not working, showed no differences between the
two groups. For a detailed description of the sociodemo-
graphic data see Table 1.
Pain characteristics
The majority of CWP patients (61.3%) and 49.0% in the
CLBP group reported long-lasting pain for more than
ten years. While CLBP patients tended to have more
pain attacks with pain-free time periods, CWP subjects
suffered more frequently from permanent pain. With
regards to the severity of chronic pain, we did not find
significant differences between the groups. Similarly, no
differences were found for the social support scale of the
MPI or for the frequency of red flags between CWP and
CLBP patients. More details about the pain characteris-
tics are shown in Table 2.
Health care
CWP patients [mean (SD) 7.3 (4.1)] received a significantly
higher number of different therapeutic strategies compared
to CLBP patients [mean (SD) 5.7 (3.6)]. However, we found
no differences in the number of GP consultations, the num-
ber of different doctors consulted, and stays in hospital dur-
ing a six-month period prior to recruitment.
Comorbidities and psychosomatic symptoms
In general, the CWP group showed a higher number of
comorbidities referring to a higher frequency of ulcer/
stomach disease, kidney disease, osteoarthritis/degenera-
tive arthritis, rheumatoid arthritis, and depression. In
comparison to CLBP patients, CWP patients suffered
more often from psychosomatic symptoms. All data are
shown in Table 3.
Discussion
To our knowledge, this project is the largest study to
date which analyzes differences between chronic local-
ized low back pain and chronic widespread pain in pri-
mary care settings.
Table 1 Sociodemographic data: differences between CLBP and CWP (n = 647)
CLBP CWP p
Chi-square test Fisher’s exact test Welch’s t-test Mann-Whitney U test
Sex [no. (%)] n = 484 n = 163 0.002 - - -
Female 279 (57.6) 117 (71.8)
Age [years: mean (SD)] n = 484 n = 163 - - 0.573 -
56.3 (14.4) 57.0 (12.6)
Marital status [no. (%)] n = 484 n = 163 0.128 - - -
Single 61 (12.6) 22 (13.5)
Married 326 (67.4) 95 (58.3)
Divorced 54 (11.2) 28 (17.2)
Widowed 43 (8.9) 18 (11.0)
Level and years of education [no. (%)] n = 482 n = 163 - 0.425 - -
13/12 years 70 (14.5) 31 (19.0)
10 years 148 (30.7) 45 (27.6)
9 years 251 (52.1) 81 (49.7)
Other graduation 11 (2.3) 4 (2.5)
No qualification 2 (0.4) 2 (1.2)
Employment status [no. (%)] n = 481 n = 163 0.046 - - -
Working (full or part-time) 254 (52.8) 71 (43.6)
Reasons for not working [no. (%)] n = 223 n = 92 - 0.796 - -
Keeping house 35 (15.7) 13 (14.1)
Retired 167 (74.9) 70 (76.1)
Unemployed 18 (8.1) 9 (9.8)
Other 3 (1.3) 0 (0)
Applied for pension [no. (%)] n = 401 n = 128 0.002 - - -
Yes 21 (5.2) 18 (14.1)
Degree of disability [no. (%)] n = 457 n = 153 0.001 - - -
Yes 176 (38.5) 83 (54.2)
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ACR criteria for CWP. Altogether, CWP patients are
predominantly female and showed more psychosomatic
symptoms and comorbidities than CLBP patients.
The observed high prevalence of CWP (25.2%) is in
accordance with the findings of Nordeman et al., who
reported a CWP prevalence of 28% in females in pri-
mary care settings [9]. The slightly higher prevalence in
the study of Nordeman et al. can be explained by the
female sample, which is associated with higher risk for
CWP [7,11].
Apart from the apparently higher proportion of females
in the CWP group, which confirms similar findings of
other investigators [7,11], we found no group differ-
ences in other sociodemographic data. Again, this obser-
vation is in accordance with the findings of Nordeman
et al. They found no significant differences in the fol-
lowing sociodemographic parameters: age, nationality,education, and social status between female CLBP and
CWP patients.
In contrast, a population-based study from Bergman
et al. found a lower educational and social status among
CWP patients [11]. There is no clear reason for this con-
trast. A possible explanation could be the different set-
ting of the populations in the study (primary care vs.
population based) and that Bergman et al. compared
CWP versus chronic regional pain in general.
The role of somatization processes in CWP is still un-
clear. In the literature, two hypotheses are discussed: First,
somatization could be a consequence of CWP. Second,
CWP could be a manifestation of the process of
somatization [11]. We only assessed typical physical symp-
toms which accompany functional dysfunctions; these
symptoms could also arise in somatic disorders. The in-
creased prevalence of these symptoms in the CWP group
emphasizes a slight association between CWP and the
Table 2 Pain anamnesis: differences between CLBP and CWP (n = 647)
CLBP CWP p






Pain in the following areas [no. (%)] n = 484 n = 163
Head 30 (6.2) 51 (31.3) <0.001 - - -
Cervical spine 161 (33.3) 125 (76.7) <0.001 - - -
Thoracic spine 198 (40.9) 115 (70.6) <0.001 - - -
Lumbar spine 484 (100) 163 (100) - - - -
Sternum 12 (2.5) 15 (9.2) 0.001 - - -
Arm – left 76 (15.7) 141 (86.5) <0.001 - - -
Arm – right 97 (20.0) 148 (90.8) <0.001 - - -
Leg – left 160 (33.1) 140 (85.9) <0.001 - - -
Leg – right 169 (34.9) 145 (89.0) <0.001 - - -
Stomach 67 (13.8) 69 (42.3) <0.001 - - -
Number of pain areas [mean (SD)] n = 484 n = 163 - - - <0.001
3.0 (1.6) 6.8 (1.5)
Body mass index [mean (SD)] n = 472 n = 162 - - 0.433 -
28.1 (5.8) 28.6 (5.9)
First time of back pain [no (%)] n = 484 n = 163 - - - <0.001
Since < 1 year ago 70 (14.5) 9 (5.5)
1-2 years ago 41 (8.5) 6 (3.7)
2-5 years ago 67 (13.8) 20 (12.3)
5-10 years ago 69 (14.3) 28 (17.2)
> 10 years ago 237 (49.0) 100 (61.3)
Back pain frequency [no (%)] n = 480 n = 163 - - - <0.001
Few times per year 40 (8.3) 1 (0.6)
Few times per month 47 (9.8) 10 (6.1)
Several times per week 89 (18.5) 21 (12.9)
One time daily 16 (3.3) 2 (1.2)
Several times per day 99 (20.6) 27 (16.6)
Permanent 189 (39.4) 102 (62.6)
Pain distribution [no (%)] n = 480 n = 163 0.001 - - -
Permanent pain with slight variations 98 (20.4) 42 (25.8)
Permanent pain with higher variations 142 (29.6) 57 (35.0)
Pain attacks, between pain free 164 (34.2) 28 (17.2)
Pain attacks, between pain 76 (15.8) 36 (22.1)
Duration of pain attacks [no (%)] n = 232 n = 62 - - - 0.013
Seconds/minutes 41 (17.7) 6 (9.7)
Hours 78 (33.6) 22 (35.5)
Days 36 (15.5) 12 (19.4)
Longer than 3 days 39 (16.8) 7 (11.3)
Longer than 1 week 38 (16.4) 15 (24.2)
Red flags [no (%)] n = 479 n = 161 0.224 - - -
Positive 89 (18.6) 37 (23.0)
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Table 2 Pain anamnesis: differences between CLBP and CWP (n = 647) (Continued)
MPI - social support subscale [mean (SD)] n = 475 n = 141 - - 0.234 -
4.8 (1.9) 4.6 (1.9)
Graded Chronic Pain (von Korff Index) [no (%)] n= 447 n = 148 - - - 0.109
0 0 (0) 0 (0)
1 72 (16.1) 11 (7.4)
2 109 (24.4) 39 (26.4)
3 131 (29.3) 50 (33.8)
4 135 (30.2) 48 (32.4)
Gut feeling: Will the pain go away? [no (%)] n = 464 n = 156 <0.001 - - -
Yes 228 (49.1) 48 (30.8)
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any causal attributions due to the cross-sectional nature of
our data, population-based cohort studies showed somatic
symptoms to be a predictive factor for the onset of CWP
[34,35]. This supports the hypothesis: CWP is a manifest-
ation of the somatization process.
In comparison to individuals without back pain [8], our
total study population has an increased prevalence of co-
morbidities. The increased rates of osteoarthritis and de-
generative arthritis, rheumatoid arthritis, depression, ulcer
or stomach diseases, and kidney diseases among CWP pa-
tients correspond with the observations of Kato et al. [15].
They extracted CWP cases and their healthy siblings from
the Swedish Twin Registry and assessed their comorbidi-
ties. A comparative analysis showed that CWP patients
have an increased odds ratio for having joint pain, depres-
sive symptoms, irritable bowel syndrome, and chronic fa-
tigue syndrome.
The increased rates of ulcer/stomach and kidney diseases
in our CWP sample might be related to a higher consump-
tion of non-steroidal anti-inflammatory drugs (NSAID).
Furthermore, ulcer and stomach diseases are typical symp-
toms of somatization processes as discussed above [36].
Apart from this, depression is a well-known comorbidity
of CWP [36]. GPs should immediately consider the parallel
comorbidities while treating CWP patients.
The definition of chronic widespread pain comprises
duration and local extension of the pain [1]. It is an op-
erational definition on a symptomatic level which does
not allow for any conclusions with respect to the aeti-
ology of CWP. Consequently, it is impossible to differen-
tiate between patients with multiple regional pain and
patients who experience a generalization of their pain by
somatic causes (e.g. arthrosis in joint, hallux valgus).
With a sensitivity of 98% and a specificity of 31% of the
current definition from the ACR [37], it is most likely
that there is a high proportion of patients in our sample
that suffers from multiple regional pain since the major-
ity of patients in general practices are older and sufferfrom multimorbidity, including degenerative diseases.
However, based on epidemiological findings, Macfarlane
postulated that a differentiation of these would be artifi-
cial and obscuring important aspects of aetiology [37].
In discussing group differences, we must emphasize
that our study population is comprised of patients with
a severe disease pattern (52%: pain > 10 years). There-
fore, we assume that our subgroups do not greatly differ
due to the already extreme nature of our subjects. This
might also be a reason for the similarity of CLBP and
CWP patients regarding pain severity according to von
Korff [28]. Both groups showed high rates of “pain re-
lated disability”, which forms the upper two grades of se-
verity independent of the dimension “pain intensity”.
With respect to methodological limitations, we have to
think of selection bias in our study. In our study, some
participations denied participation due to the long, de-
manding questionnaire. Selective recruitment might
have occurred because general practitioners might forget
to recruit patients due to a high workload. Furthermore,
it might be possible that GPs are more likely to recruit
special cases (e.g., patients with higher disease severity
or unique personality). This might reduce the external
validity of our results.
Although a GP recruitment rate of about 20% is normal
in our research field, we should consider selection bias.
We do not know if non-participating GPs have CLBP pa-
tients with characteristics different than the participating
GPs. However, regarding sociodemographic data and prac-
tice characteristics, the GP sample seems to be representa-
tive for the region of northern Hessen.
Conclusion
Our primary finding is the high CWP prevalence among
CLBP patients in primary care settings. Therefore, CWP is
a frequent and particularly severe pain syndrome. Al-
though it is impossible to identify CWP patients with the
help of typical sociodemographic profiles, we showed that
CWP patients are more likely to suffer from psychosomatic










Self-Administered Comorbidity Questionnaire (SACQ)
Disease areas (problems) [no (%)]
High blood pressure (n = 632) n = 472 n = 160 0.079 - - -
210 (44.5) 84 (52.5)
Heart diseases (n = 611) n = 460 n = 151 0.489 - - -
57 (12.4) 22 (14.6)
Asthma (n = 608) n = 458 n = 150 0.730 - - -
65 (14.2) 23 (15.3)
Chronic obstructive pulmonary disease (n = 594) n = 450 n = 144 0.862 - - -
46 (10.2) 14 (9.7)
Ulcer or stomach diseases (n = 605) n = 455 n = 150 0.014 - - -
77 (16.9) 39 (26.0)
Diabetes (n = 609) n = 462 n = 147 0.763 - - -
61 (13.2) 18 (12.2)
High blood lipid level (n = 607) n = 454 n = 153 0.272 - - -
130 (28.6) 51 (33.3)
Kidney diseases (n = 602) n = 454 n = 148 0.011 - - -
33 (7.3) 21 (14.2)
Osteoarthitis, degenerative arthritis (n = 619) n = 462 n = 157 <0.001 - - -
192 (41.6) 96 (61.1)
Rheumatoid arthritis (n = 591) n = 445 n = 146 0.005 - - -
48 (10.8) 29 (19.9)
Osteoporosis (n = 597) n = 447 n = 150 0.454 - - -
44 (9.8) 18 (12.0)
Cancer disease (n = 600) n = 453 n = 147 0.287 - - -
33 (7.3) 7 (4.8)
Depression (n = 598) n = 456 n = 142 <0.001 - - -
84 (18.4) 47 (33.1)
Other psychiatric diseases (n = 596) n = 449 n = 147 0.354 - - -
54 (12.0) 22 (15.0)
Number of diagnosed problems [mean (SD)] n = 383 n = 118
2.2 (1.9) 2.9 (2.1) - - - 0.001
Number of treated problems [mean (SD)] n = 366 n = 107
1.3 (1.5) 1.8 (1.9) - - - 0.026
Summary score [mean (SD)] n = 331 n = 102
3.5 (3.6) 5.0 (4.6) - - 0.003 -
Symptom Checklist-90-R n = 430 n = 143
Summation of all items [mean (SD)] 10.0 (5.9) 15.0 (7.6) - - <0.001 -
Mean of all items [mean (SD)] 0.8 (0.5) 1.3 (0.6) - - <0.001 -
Number of symptoms [mean (SD)] 5.6 (2.8) 7.8 (3.0) - - <0.001 -
Viniol et al. BMC Musculoskeletal Disorders 2013, 14:351 Page 7 of 9
http://www.biomedcentral.com/1471-2474/14/351
Viniol et al. BMC Musculoskeletal Disorders 2013, 14:351 Page 8 of 9
http://www.biomedcentral.com/1471-2474/14/351symptoms and comorbidities than CLBP patients. These
comorbidities must be considered when a GP makes
treatment decisions based on the fact that a patient has
CWP. Further research is needed to clarify the role of
somatization in conjunction with chronic widespread pain
to infer the direction of causality.
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